cas 940999-74-6|| where to buy 2-[4-(azepane-1-sulfonyl)phenyl]-5-[(4-ethoxyphenyl)amino]-1,3-oxazole-4-carbonitrile

Nombre del producto:2-[4-(azepane-1-sulfonyl)phenyl]-5-[(4-ethoxyphenyl)amino]-1,3-oxazole-4-carbonitrile

IUPAC Name:2-[4-(azepane-1-sulfonyl)phenyl]-5-[(4-ethoxyphenyl)amino]-1,3-oxazole-4-carbonitrile

Unidad de embalaje	Stock disponible	Precio($)	Cantidad

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 940999-74-6 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :940999-74-6; Fórmula molecular:C24H26N4O4S; Punto de fusión:-; Código de sonrisas:CCOC1=CC=C(NC2=C(N=C(O2)C2=CC=C(C=C2)S(=O)(=O)N2CCCCCC2)C#N)C=C1; Densidad:

: Número de catálogo:CM677867; Peso molecular:466.56; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Oxazoles; Oxazoles are heterocyclic aromatic compounds containing one oxygen atom and one nitrogen atom, separated by a carbon atom. The presence of two heteroatoms (oxygen and nitrogen) provides possible interactions (hydrogen, hydrophobic, van der Waals or dipole bonds) with a wide range of receptors and enzymes. Oxazole rings are valuable heterocyclic scaffolds for the design of novel therapeutics with anticancer, antiviral, antibacterial, anti-inflammatory, neuroprotective, antidiabetic, and antidepressant properties due to their wide range of targets and biological activities.

: Azepanes; The use of azepane as a scaffold for drug discovery remains of interest. The azepane linker is the key to efficient activity. A number of seven-membered ring derivatives have been prepared or investigated for their potential or actual pharmacological properties. Examples include azaalkane derivatives as PKB (protein kinase B) inhibitors.